| Date | Title | Description |
| 30.12.2024 | Knowledge Intensive EIS Fund IV launch |
We are pleased to announce the launch of the Parkwalk Knowledge Intensive EIS Fund IV, an HMRC-approved EIS Fund. The fourth Knowledge Intensive Fund will back cutting-edge technology companies spun out of leading UK universities and resea... |
| 12.11.2023 | Parkwalk – launches Knowledge Intensive EIS Fund III | We are pleased to announce the launch of the Parkwalk Knowledge Intensive EIS Fund III, an HMRC-approved EIS Fund. As featured in Investment Week, the third Knowledge Intensive Fund will back cutting-edge technology companies spun out of le... |
| 09.09.2021 | What Andreessen Horowitz’s recent hiring surge says about the venture capital investor | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content 4 ways CEOs can build a successful cloud strategy From PWC
Andreessen Horowitz has m... |
| 09.09.2021 | What Andreessen Horowitz’s recent hiring surge says about the venture capital investor | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Andreessen Horowitz has made itself into a premier venture capital investing shop on Sand Hill Ro... |
| 08.09.2021 | PetMedix raises $37M Series B | PetMedix raises $37M Series B
“PetMedix has a global vision: elevating expectations in pet care the world over. This financing round not only provides the capital required to take us to the next level, but also the international perspective... |
| 08.09.2021 | PetMedix Raises $37M in Series B Funding | PetMedix, a Cambridge UK-based animal health company, raised $37M in Series B funding.
The round was led by Tencent and Kyoritsu Holdings with participation from Digitalis Ventures, Parkwalk Advisors and Cambridge Innovation Capital.
The co... |
| 07.09.2021 | PetMedix raises £27m Series B | PetMedix™ announces today the completion of an oversubscribed £27m ($37m) Series B financing round that will be used to advance its innovative pipeline through clinical development.
The investment brings two new investors into PetMedix: glo... |
| 21.07.2021 | PetMedix monoclonal antibodies outperform benchmarks in canine study | PetMedix monoclonal antibodies outperform benchmarks in canine study
Successful performance of first-ever fully canine antibodies in dog trial paves the way for next-generation technology to meet therapeutic needs in fast growing pet healt... |
| 17.03.2021 | PetMedix and Start Codon shortlisted for the Business Weekly Awards | PetMedix and Start Codon shortlisted for the Business Weekly Awards
Initial shortlist unveiled for Business Weekly Awards
Business Weekly article | By Tony Quested
The addition of two particular categories has helped produce a brilliant ini... |
| 18.02.2021 | 4 startups that show us what is coming next for pet health | 4 startups that show us what is coming next for pet health
Antibody treatments, wellness testing, health chatbots and Tinder for dogs
Sifted article | By Maija Palmer
Anything we do for human health is being translated into veterinary servi... |
| 27.01.2021 | A year in review: Business update January 2021 | Cambridge has always been at the forefront of innovation. As the leading venture capital investor in Cambridge, CIC plays a central role in commercialising this innovation for the benefit of society. In the last year, CIC’s existing portfol... |
| 12.01.2021 | PetMedix enters into partnership with Boehringer Ingelheim | PetMedix enters into partnership with Boehringer Ingelheim
Boehringer Ingelheim has entered into a partnership with PetMedix, a UK based research and development stage biopharmaceutical company.
Strengthening partnerships to accelerate inno... |
| 18.11.2020 | CIC news November 2020 | I am delighted to share the first edition of our newsletter which we are distributing to our colleagues, investors, co-investors and fellow stakeholders in the Cambridge innovation ecosystem.
Our plan is to provide updates on the activities... |
| 04.11.2020 | Carol Cheung and PetMedix named in Cofinitive's #21toWatch nominee list | The #21toWatch Campaign and Awards
CIC's Carol Cheung and portfolio company PetMedix have been named in Cofinitive's #21toWatch list of nominees for the 2021 awards.
People, companies and the ‘things’ they create, across Cambridge and the E... |
| 03.11.2020 | PetMedix named in Top 10 promising pet startups by EU Startups | PetMedix named in Top 10 promising pet startups that are keeping pets and pet lovers happy during the pandemic
EU Startups article | by Charlotte Tucker
If you’ve been spending more time (and money) on your pets recently, then you’re not al... |
| 10.07.2020 | BioMed Realty fully leases flagship life sciences development at Babraham Research Campus within 12 months as first occupier moves in | BioMed Realty fully leases flagship life sciences development at Babraham Research Campus within 12 months as first occupier moves in
10-07-2020
BioMed Realty, a Blackstone portfolio company, has completed the lease-up of its landmark schem... |
| 22.06.2020 | Annual results for the year ended 31 March 2020 | Expansion to 30 portfolio companies and 46% increase in net asset value, reinforcing CIC’s position as the most active series A investor in the Cambridge ecosystem
Cambridge Innovation Capital plc (CIC), the venture capital investor enablin... |
| 19.05.2020 | PetMedix demonstrates ability to raise critical investment at a time of uncertainty | UK-based start-up PetMedix has highlighted the resilience of the companion animal health space by capturing equity investment from a local backer.
AnimalPharm article by Joseph Harvey | @JHJournalist | joseph.harvey@ihsmarkit.com
The firm g... |
| 19.05.2020 | CIC invests in PetMedix | Cambridge Innovation Capital (CIC), is pleased to announce it has invested in PetMedix, a Cambridge, UK-based biopharmaceutical company developing antibody-based therapeutics for companion animals.
PetMedix has developed an innovative platf... |
| 21.02.2020 | PetMedix wins Best Start-up 2019 in the Animal Pharm Awards | PetMedix wins Best Start-up 2019 in the Animal Pharm Awards
21-02-2020
PetMedix has been voted best start-up in the global Animal Pharm Awards. The UK-based start-up is developing a new tier of monoclonal antibody therapy for the animal hea... |
| 17.10.2019 | BioMed Realty announces first lettings at Babraham Research Campus in Cambridge | BioMed Realty announces first lettings at Babraham Research Campus in Cambridge
17-10-2019
Set to open in April 2020, BioMed Realty's Babraham Research Campus buildings are now more than 50% let or under offer, highlighting the thriving lif... |
| 17.10.2019 | BioMed Realty announces first lettings at Babraham Research Campus in Cambridge | Set to open in April 2020, BioMed Realty's Babraham Research Campus buildings are now more than 50% let or under offer, highlighting the thriving life science industry in Cambridge.
Today, BioMed Realty, the leading provider of real estate ... |
| 02.07.2019 | PetMedix set to transform companion animal health with monoclonal antibody innovation | PetMedix set to transform companion animal health with monoclonal antibody innovation
02-07-2019
PetMedix is developing cutting-edge monoclonal antibody technology with the potential to transform a wide range of veterinary treatment options... |
| - | PetMedix – closes $37m Series B round | Parkwalk are pleased to announce an investment in PetMedix a Cambridge University spin out, leading the way in antibody innovation in animal health. Parkwalk co-led the $37m Series B funding round with Digitalis Ventures. |
